Sökning: WFRF:(Sesso Howard D) >
Immunohistochemical...
Immunohistochemical Expression of BRCA1 and Lethal Prostate Cancer
-
- Fiorentino, Michelangelo (författare)
- Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
-
- Judson, Gregory (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Epidemiology, Harvard School of Public Health, Boston, USA
-
- Penney, Kathryn (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Epidemiology, Harvard School of Public Health, Boston, USA
-
visa fler...
-
- Flavin, Richard (författare)
- Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
-
- Stark, Jennifer (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Epidemiology, Harvard School of Public Health, Boston, USA
-
- Fiore, Christopher (författare)
- Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
-
- Fall, Katja, 1971- (författare)
- Karolinska Institutet,Uppsala University Hospital
-
- Martin, Neil (författare)
- Department of Epidemiology, Harvard School of Public Health, Boston, USA; Radiation Oncology, Brigham and Women's Hospital, Boston, USA
-
- Ma, Jing (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
-
- Sinnott, Jennifer (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Biostatistics, Harvard School of Public Health, Boston, USA
-
- Giovannucci, Edward (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Epidemiology, Harvard School of Public Health, Boston, USA; Department of Nutrition, Harvard School of Public Health, Boston, USA
-
- Stampfer, Meir (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Epidemiology, Harvard School of Public Health, Boston, USA; Department of Nutrition, Harvard School of Public Health, Boston, USA
-
- Sesso, Howard D. (författare)
- Department of Epidemiology, Harvard School of Public Health, Boston, USA; Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
-
- Kantoff, Philip W. (författare)
- Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Broad Institute, Cambridge, USA
-
- Finn, Stephen (författare)
- Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
-
- Loda, Massimo (författare)
- Department of Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; Broad Institute, Cambridge, USA
-
- Mucci, Lorelei (författare)
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Epidemiology, Harvard School of Public Health, Boston, USA
-
visa färre...
-
(creator_code:org_t)
- Philadelphia, USA : American Association for Cancer Research, 2010
- 2010
- Engelska.
-
Ingår i: Cancer Research. - Philadelphia, USA : American Association for Cancer Research. - 0008-5472 .- 1538-7445. ; 70:8, s. 3136-3139
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BRCA1 functions as a tumor suppressor; recent work suggests that BRCA1 may also induce cell cycle arrest to allow for DNA repair. We hypothesized that BRCA1 expression in prostate tumor tissue may be associated with prostate cancer progression through regulation of the cell cycle. We used immunohistochemistry to evaluate BRCA1 protein expression in archival tumor samples from 393 prostate cancer cases in the Physicians' Health Study. The men were followed prospectively from diagnosis to development of metastases and mortality. Fifteen percent of tumors stained positive for BRCA1. BRCA1-positive tumors had substantially increased tumor proliferation index compared with negative tumors (47.0 Ki67-positive nuclei versus 10.3, P = 0.0016) and were more likely to develop lethal cancer compared with BRCA1-negative tumors (hazard ratio, 4.6; 95% confidence interval, 2.4-8.7). These findings strengthen the hypothesis that BRCA1 plays a role in cell cycle control and show that BRCA1 is a marker of clinical prostate cancer prognosis. Cancer Res; 70(8); 3136-9. (C) 2010 AACR.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Fiorentino, Mich ...
-
Judson, Gregory
-
Penney, Kathryn
-
Flavin, Richard
-
Stark, Jennifer
-
Fiore, Christoph ...
-
visa fler...
-
Fall, Katja, 197 ...
-
Martin, Neil
-
Ma, Jing
-
Sinnott, Jennife ...
-
Giovannucci, Edw ...
-
Stampfer, Meir
-
Sesso, Howard D.
-
Kantoff, Philip ...
-
Finn, Stephen
-
Loda, Massimo
-
Mucci, Lorelei
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
Cancer Research
- Av lärosätet
-
Uppsala universitet
-
Örebro universitet
-
Karolinska Institutet